Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation

Details for Australian Patent Application No. 2006212807 (hide)

International Classifications

Event Publications

29 November 2007 Section 223 Application Received

ZymoGenetics, Inc. An application to extend the time from 16 Aug 2006 to 16 Aug 2007 in which to enter the National Phase has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

24 January 2008 Section 223 Application Allowed

ZymoGenetics, Inc. The time in which to enter the National Phase has been extended to 16 Aug 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

31 January 2008 PCT application entered the National Phase

PCT publication WO2006/086396 Priority application(s): WO2006/086396

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.